Skip to content
10-Q

Quarterly Report

Aprea Therapeutics, Inc. APRE

0001558370-25-011152

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 5.83M sh
Shares Diluted Q2 2025 · Jun 30, 2025 6.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 6.04M sh
Shares Diluted Q2 2025 · Jun 30, 2024 5.94M sh
Shares Diluted Q2 2025 · Jun 30, 2024 5.07M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.76M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7.58M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $16.53M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $22.85M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $28.69M
Stockholders Equity Q2 2025 · Jun 30, 2025 $13.41M
Stockholders Equity Q2 2025 · Mar 31, 2025 $15.55M
Stockholders Equity Q2 2025 · Dec 31, 2024 $19.31M
Stockholders Equity Q2 2025 · Jun 30, 2024 $25.56M
Stockholders Equity Q2 2025 · Mar 31, 2024 $28.92M
Stockholders Equity Q2 2025 · Dec 31, 2023 $16.95M
Current Liabilities Q2 2025 · Jun 30, 2025 $3.17M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.36M
Current Assets Q2 2025 · Jun 30, 2025 $16.93M
Current Assets Q2 2025 · Dec 31, 2024 $23.58M
Total Assets Q2 2025 · Jun 30, 2025 $17.31M
Total Assets Q2 2025 · Dec 31, 2024 $23.98M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.53
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.19
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.58
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.24
Eps Basic Q2 2025 · Jun 30, 2025 −$0.53
Eps Basic Q2 2025 · Jun 30, 2025 −$1.19
Eps Basic Q2 2025 · Jun 30, 2024 −$0.58
Eps Basic Q2 2025 · Jun 30, 2024 −$1.24
Sga Expense Q2 2025 · Jun 30, 2025 $1.59M
Sga Expense Q2 2025 · Jun 30, 2025 $3.36M
Sga Expense Q2 2025 · Jun 30, 2024 $1.85M
Sga Expense Q2 2025 · Jun 30, 2024 $3.78M
Net Income Q2 2025 · Jun 30, 2025 −$3.24M
Net Income Q2 2025 · Jun 30, 2025 −$7.17M
Net Income Q2 2025 · Mar 31, 2025 −$3.93M
Net Income Q2 2025 · Jun 30, 2024 −$3.47M
Net Income Q2 2025 · Jun 30, 2024 −$6.28M
Net Income Q2 2025 · Mar 31, 2024 −$2.81M
Operating Income Q2 2025 · Jun 30, 2025 −$3.39M
Operating Income Q2 2025 · Jun 30, 2025 −$7.47M
Operating Income Q2 2025 · Jun 30, 2024 −$3.85M
Operating Income Q2 2025 · Jun 30, 2024 −$7M
Capex Q2 2025 · Jun 30, 2024 $15.48K